Versatile near -infrared fluorescent probe for in vivo detection of Af3 oligomers

被引:21
作者
Zeng, Fantian [1 ,2 ]
Yang, Jian [1 ,2 ]
Li, Xiaofang [1 ,2 ]
Peng, Kewen [2 ]
Ran, Chongzhao [3 ,4 ]
Xu, Yungen [1 ,2 ]
Li, Yuyan [1 ,2 ]
机构
[1] China Pharmaceut Univ, State Key Lab Nat Med, Nanjing 210009, Peoples R China
[2] China Pharmaceut Univ, Dept Med Chem, Jiangsu Key Lab Drug Design & Optimizat, Nanjing 21198, Peoples R China
[3] Massachusetts Gen Hosp, Athinoula A Martinos Ctr Biomed Imaging, Boston, MA 02129 USA
[4] Harvard Med Sch, Boston, MA 02129 USA
基金
中国博士后科学基金; 中国国家自然科学基金;
关键词
AMYLOID-BETA OLIGOMERS; ALZHEIMERS-DISEASE; A-BETA; SYNAPTIC PLASTICITY; PLAQUES; PROTEIN; BIOMARKERS; DESIGN;
D O I
10.1016/j.bmc.2020.115559
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Amyloid-β oligomers (AβOs) enrichment in brain is highly related to Alzheimer's pathogenesis, but tracing them in the brain by imaging technique is still a great challenge due to their heterogeneity and metastability. Herein, a new near-infrared (NIR) fluorescent probe, namely, PTO-41, was designed and synthesized to specifically target AβOs. PTO-41 possesses excellent functional properties including optimal fluorescent properties (emission maxima at 680 nm upon interacting with AβOs), high affinity (Kd = 349 nM), low cell toxicity, desirable lipophilicity (log P = 2.24), and fast wash out from the brain (brain2 min/brain60 min = 5.0). Furthermore, PTO-41 exhibits a high sensitivity toward AβOs in vitro phantom imaging experiments. More importantly, PTO-41 shows great capacity to differentiate between 4-month-old APP/PS1 model mice from age-matched control mice using in vivo imaging. In summary, PTO-41 almost meets all the requirements as a versatile NIR fluorescent probe for the detection of AβOs both in vitro and in vivo. © 2020 Elsevier Ltd
引用
收藏
页数:8
相关论文
共 35 条
[1]  
[Anonymous], 2012, BMC RES NOTES, DOI DOI 10.1186/1756-0500-5-185
[2]   Probing the Biology of Alzheimer's Disease in Mice [J].
Ashe, Karen H. ;
Zahs, Kathleen R. .
NEURON, 2010, 66 (05) :631-645
[3]   Biomarkers in Alzheimer's disease drug development [J].
Blennow, Kaj .
NATURE MEDICINE, 2010, 16 (11) :1218-1222
[4]   Therapeutics for Alzheimer's disease based on the Metal Hypothesis [J].
Bush, Ashley I. ;
Tanzi, Rudolph E. .
NEUROTHERAPEUTICS, 2008, 5 (03) :421-432
[5]   Smart Near-Infrared Fluorescence Probes with Donor-Acceptor Structure for in Vivo Detection of β-Amyloid Deposits [J].
Cui, Mengchao ;
Ono, Masahiro ;
Watanabe, Hiroyuki ;
Kimura, Hiroyuki ;
Liu, Boli ;
Saji, Hideo .
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, 2014, 136 (09) :3388-3394
[6]   Design and synthesis of new theranostic agents for near-infrared imaging of β-amyloid plaques and inhibition of β-amyloid aggregation in Alzheimer's disease [J].
Dao, Pascal ;
Ye, Feifei ;
Du, Zhi Yun ;
Chen, Qian ;
Zhang, Kun ;
Dong, Chang Zhi ;
Meunier, Bernard ;
Chen, Huixiong .
DYES AND PIGMENTS, 2017, 147 :130-140
[7]   In vivo near-infrared fluorescence imaging [J].
Frangioni, JV .
CURRENT OPINION IN CHEMICAL BIOLOGY, 2003, 7 (05) :626-634
[8]   Amyloid-β Deposits Target Efficient Near-Infrared Fluorescent Probes: Synthesis, in Vitro Evaluation, and in Vivo Imaging [J].
Fu, Hualong ;
Tu, Peiyu ;
Zhao, Liu ;
Dai, Jiapei ;
Liu, Boli ;
Cui, Mengchao .
ANALYTICAL CHEMISTRY, 2016, 88 (03) :1944-1950
[9]   Highly Sensitive Near-Infrared Fluorophores for in Vivo Detection of Amyloid-β Plaques in Alzheimer's Disease [J].
Fu, Hualong ;
Cui, Mengchao ;
Zhao, Liu ;
Tu, Peiyu ;
Zhou, Kaixiang ;
Dai, Jiapei ;
Liu, Boli .
JOURNAL OF MEDICINAL CHEMISTRY, 2015, 58 (17) :6972-6983
[10]   Evaluation of molecules based on the electron donor-acceptor architecture as near-infrared β-amyloidal-targeting probes [J].
Fu, Hualong ;
Cui, Mengchao ;
Tu, Peiyu ;
Pan, Ziwei ;
Liu, Boli .
CHEMICAL COMMUNICATIONS, 2014, 50 (80) :11875-11878